Senesco Technologies (NYSE:ELOX) will post its quarterly earnings results before the market opens on Wednesday, August 7th. Analysts expect Senesco Technologies to post earnings of ($0.37) per share for the quarter.
Senesco Technologies (NYSE:ELOX) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.33) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.08.
Shares of NYSE:ELOX opened at $6.98 on Tuesday. Senesco Technologies has a 1 year low of $6.86 and a 1 year high of $18.50. The firm’s fifty day simple moving average is $8.97.
Eloxx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations.
Further Reading: What is Net Asset Value (NAV)?
Receive News & Ratings for Senesco Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senesco Technologies and related companies with MarketBeat.com's FREE daily email newsletter.